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Available online 18 October 2016Background: Pathophysiology of attention-deﬁcit hyperactivity disorder (ADHD) is not known, and therefore the
present study investigated mitochondrial defects, if any in cybrids created from patients and control population.
Methods: To investigate mitochondrial pathology in ADHD, cybrids cell lines were created from ADHD probands
and controls by fusing their platelets with ρ0-cells prepared from SH-SY5Y neuroblastoma cell line. Cellular
respiration, oxidative stress, mitochondrial membrane potential and morphology were evaluated employing
oxygraph, mitochondria-speciﬁc ﬂuorescence staining and evaluation by FACS, and immunocytochemistry.
HPLC-electrochemical detection, quantitative RT-PCR and Blue Native PAGE were employed respectively for as-
says of serotonin, mitochondrial ATPase 6/8 subunits levels and complex V activity.
Results: Signiﬁcantly low cellular and mitochondrial respiration, ATPase6/8 transcripts levels, mitochondrial com-
plex V activity and loss of mitochondrial membrane potential and elevated oxidative stress were observed in
ADHD cybrids. Expression of monoamine oxidizing mitochondrial enzymes, MAO-A and MAO-B levels remained
unaffected. Two-fold increase in serotonin level was noted in differentiated cybrid-neurons.
Conclusions: Since cybrids are shown to replicatemitochondrial defects seen in post-mortem brains, these observed
defects in ADHD cybrids strongly suggest mitochondrial pathology in this disorder.
General signiﬁcance:Mitochondrial defects are detected in ADHD cybrids created from patients' platelets,
implying bioenergetics crisis in the mitochondria could be a contributory factor for ADHD pathology
and/or phenotypes.








Inattention, impulsiveness and hyperactivity depict phenotypes of
attention-deﬁcit hyperactivity disorder (ADHD), a heritable and hetero-
geneous childhood disorder with a prevalence of 6-7% in children and
adolescents [1]. Mitochondrial dysfunction is a suggested vulnerability
factor in the pathogenesis of various neuropsychiatric disorders [2–5].
Bioenergetic crisis during brain development, mitochondrial DNA
(mtDNA) mutation or deletion may cause neurodevelopmental
disorders. Autism spectrum disorder probands with mitochondrial
defects exhibit symptoms of ADHD [6–8], suggesting possibility ofr Biomedical Research & Super
s at Thalappady, Rubber Board
yahoo.com
. This is an open access article underbioenergetics defects in ADHD too [9]. Other than a report on signiﬁcant
stimulant effect of the ADHD drug, methylphenidate on neuronal ﬁring
and mitochondrial transport chain (ETC) enzyme activities in rats [10],
no report is available on direct involvement of mitochondrial defects
in ADHD. We investigated involvement, if any of mitochondrial
bioenergetics in the pathophysiology of ADHD, by creating control and
ADHD cybrids from an Indian population.
Cybrids, the mitochondrial transgenic cells created by fusion of
mitochondria-less neuronal ρ0-cell lines with blood platelets from pa-
tients, mimic pathological conditions of disease phenotypes of post-
mortem brains as shown for Parkinson’s disease [11] and other diseases
[12].We created cybrids using blood platelets fromADHDprobands and
ethnically-matched controls, and investigated their mitochondrial
status and functions. One-time creation of cybrids has advantage over
repeated blood sampling from young volunteers, since cybrids could
be cryopreserved, differentiated into neurons and used continually for
investigations.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Materials
The human neuroblastoma cell line SH-SY5Y was obtained from
National Centre for Cell Sciences, Pune, India. Low glucose Dulbecco’s
modiﬁed Eagle’s medium, minimal essential medium modiﬁed
for suspension culture (S-MEM), fetal bovine serum, Gentamicin,
tetramethylrhodamine, methyl ester (TMRM), were procured from
GIBCO, InvitrogenCorporation (CA, USA). Lymphocyte separationmedi-
um (LSM), polyethylene glycol 1000, manitol, were purchased fromMP
Biomedicals (France). PicoGreen®, MitoSOX™ were purchased from
Molecular probes (OR, USA). Potassium chloride, KH2PO4, NaCl and
Na2HPO4.2H2O,magnesiumsulfate, leadnitrate, sucrose, were procured
from Sisco Research laboratories (India). Amphotericin B, pyruvate,
uridine, ethidium bromide, TRI reagent, 6-aminocaproic acid, Bis-Tris
HCl, N-Dodecyl β-D-Maltoside, bis acrylamide, ATP, EGTA were
purchased from Sigma (MO, USA). Coomassie Brilliant Blue G-250 and
R-250 dyes were purchased from BioRad (CA, USA) and acrylamide
was purchased from Merck (Darmstadt, Germany).
2.2. Methods
2.2.1. Cybrid preparation
ADHD probands (two aged 13; one aged 10 years) and ethnically-
matched controls (a 5 years-old female, three males- 5 years, 6 years
8 months and 9 years old respectively) were recruited by mental
health professionals of Manovikas Kendra following psychological
evaluations through Conners’ Parents and Teachers Rating Scale [13]
and Wechsler’s Intelligence Scale for Children [14] for assessing
inattention/hyperactivity and Intelligence Quotient (IQ) levels, respec-
tively. Patients with other neuropsychiatric disorders, pervasive
developmental disorders, mental retardation (IQ N70) including
Fragile-X syndrome were excluded. Informed written consent for
participationwas obtained from the parents. Institutional Human ethics
committee approved the study protocol.
2.2.2. Conﬁrmation of mtDNA transfer
ρ0-Cells prepared from SH-SY5Y cell line were fused with platelets
isolated from 3 ADHD male probands and two healthy controls to
produce cybrids [15]. Genomic-DNA isolated from SH-SY5Y, ρ0-cells
and cybrids created were subjected to long template PCR using internal
primers that amplify a 5.8 kb fragment present in both nuclear and
mitochondrial genomes and the amplicon was nested with external
primers to amplify a 5.9 kb mtDNA-sequence [16]. PicoGreen® and
Mitotracker Green® (Invitrogen Corporation, CA) staining were used
for examining absence and presence of mtDNA in these cells and to
locate mitochondria in live cells, respectively. Images of cells stained
with PicoGreen® or Mitotracker Green® were captured using confocal
microscope.
2.2.3. Mitochondrial membrane potential and oxidative stress
Mitochondrial membrane potential was evaluated by staining cells
with tetramethylrhodamine, methyl ester (TMRM). Equal number
(1 × 106 for ﬂuorimetry and 2 × 105 for ﬂowcytometry) of cells were
plated in 6 well plates for TMRM staining. Next day cells were
trypsinized and the pellet was resuspended in freshmedium containing
50 nMTMRM, incubated at 37 °C for 30min in the dark in a CO2 incuba-
tor. The medium containing the stain was then removed and the cells
were washed twice with D-PBS. Red ﬂuorescence was measured using
a spectroﬂuorimeter (PerkinElmer, USA). The excitation and emission
wavelengths for TMRM stainingwere 530 nm and 570 nm respectively.
Membrane potential was also measured with the same dye by
using ﬂowcytometry in cybrids. Cells were processed in the same
way and the population of TMRM stained cells was analysed byﬂowcytometry (BD LSRFortessa ﬂuorescence activated cell sorting
(FACS), Software-FACS Diva 6.2.).
Cells were stainedwithMitoSOX™ to assessmitochondrial superox-
ide generation in these cybrids. Cybridswere collected by trypsinization
and stainedwith 2.5 μMofMitoSOX™ for 30min at 37 °C in the dark in a
CO2 incubator. The stain containingmediumwas then removed and the
cells were washed twice with D-PBS. Red ﬂuorescence was measured
using a spectroﬂuorimeter (PerkinElmer, USA, excitation: 510 nm,
emission: 580 nm). MitoSOX™ stained cells were also analysed by
ﬂowcytometry (BD LSRFortessa ﬂuorescence activated cell sorting
(FACS), Software-FACS Diva 6.2.) [19].
2.2.4. Respiration
Whole cell respiration and digitonin permeabilized cells’ mitochon-
drial respiration were measured in cybrids using Oxygraph respirome-
ter (Hansatech Instruments Ltd, England). Cells were trypsinized and
added to the counter chamber of the Oxygraph respirometer containing
D-PBS and the rate of oxygen consumptionwasmeasured for 8min. For
mitochondrial respiration the cells were permeabilized with digitonin
(0.01%), in mitochondria isolation buffer (MIB, 225 mM Manitol,
75 mM Sucrose, 5 mMMOPs, 1 mM EGTA, dissolved in water, pH 7.4).
The cells were washed two times to remove traces of digitonin and ox-
ygen consumption was measured for 10 min. The representation of the
amount of oxygen consumedwas given as nmol of oxygen/min/number
of cells use. [17].
2.2.5. Transcriptome analysis of ATP6/8 subunits
For real time PCR, RNA was isolated using TRI reagent according to
the manufacturer’s protocol. Five μg of the total RNA was reverse
transcribed using MuLV reverse transcriptase (conditions: 70 °C for
5 min, 37 °C for 5 min, then 42 °C for 60 min, and 70 °C 10 min, ﬁnal
hold at 4 °C). Relative quantiﬁcation was performed using real-time
PCR (Thermal Cycler Dice Real Time System TP800, Takara, Japan)
with 100 ng of cDNA and SYBR Premix. The thermal cycling involved
initial denaturation of 95 °C for 5 min followed by 40 cycles of 95 °C
for 20 s, 58 °C for 30 s, 72 °C for 20 s. 18sRNA was used as endogenous
control. The primers were designed using Primer 3 software (ATPase 6
- Forward 5'-GCCCTAGCCCACTTCTTACC-3', Reverse 5'-TTAAGGCGACA
GCGATTTCT-3'; ATPase 8 - Forward 5'-CACCTACCTCCCTCACCAAA-3’,
Reverse 5'-CTAGGATTGTGGGGGCAAT-3', 18srRNA – Forward 5’-CATG
GCCGTTCTTAGTTGGT-3’, Reverse 5’ CGGACATCTAAGGGCATCAC-3’),
data were analyzed using the 2-ΔΔCT method [18].
2.2.6. Complex V activity
For Blue Native - Polyacrylamide gel electrophoresis (BN-PAGE),
mitochondria (P2 fraction) were isolated in mitochondria isolation
buffer (MIB, 225 mM Manitol, 75 mM Sucrose, 5 mM MOPs, 1mM
EGTA, dissolved in water, pH 7.4), after quantiﬁcation stored in -800C.
Next day pellet was dissolved in sample buffer (1 M 6-
aminocaproic acid and 50 mM Bis-Tris HCl, dissolved in water,
pH 7.0), along with freshly prepared 10% (w/v) N-Dodecyl β-D-
Maltoside, kept on ice for 10 min to dissolve the membrane proteins
in the solution. Centrifuge the samples at 20,000xg for 30 min at 40C.
Collect the supernatant and add the gel loading buffer (5% w/v
Coomassie Brilliant Blue G-250 dissolved in 1 M 6-aminocaproic acid).
Gradient gel (5-13%)was prepared by using30% acrylamide solution
(by dissolving 29.22 g of acrylamide, 0.78 g of bis acrylamide in 100 ml
of distilled water) in gel buffer (150mMBis-Tris, 1.5 mM aminocaproic
acid, pH 7.0). The sample protein (60 μg) was run at, 100 V for 4 hrs
at 4 0C on this gradient gel using 1X Cathode Buffer (10X Cathode
Buffer- 50 mM Tricine, 15 mM bis-Tris HCl, pH 7.0, 0.02% Coomassie
G-250) and 1X Anode buffer (10X Anode buffer- 500 mM Bis-Tris HCl,
pH 7.0). Two gels were run using same protein, once run was complete
one gel was kept for coomassie staining (for protein quantiﬁcation,
0.25 % coomassie brilliant blue R250 in 40% methanol, 7% acetic acid)
for one hour and distained overnight in 10% acetic acid and 10%
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tris, 270 mM glycine, 14 mM magnesium sulfate, 0.2 % lead nitrate,
8 mM ATP, pH 7.8) for overnight at room temperature. Next day gels
were photographed, reaction gels shows white bands [19].
2.2.7. Serotonin analysis
For HPLC analysis 5×105 cells were plated and differentiated for six
days. On the seventh day, themediumwas replacedwith freshmedium.
After 16 h the cells were washed, sonicated in 50 μl of ice-cold 0.4 M
perchloric acid, centrifuged at 12,500 rpm for 5 min and 10 μl of the
supernatant was injected into the HPLC-ECD system. A standard
solution containing 4 pmol of all the biogenic amines (Norepinephrine,
DOPAC, Dopamine, 5-HIAA, HVA and 5-HT)were assayed prior to and at
the end of the sample injections to conﬁrm the retention time of
the analytes in the column. The ﬂow rate was 0.7 ml/min and the
electrochemical detection was performed at 0.74 V. The sensitivity of
the HPLC-ECD was set at 20 nA [21].
Cybrids cultured on poly-L-lysine coated cover-slips at 105 cells/ml/
35 mm dish were immunostained for monoamine oxidase-A (MAO-A)
and MAO-B proteins, images were captured employing confocal
microscope, and ﬂuorescence Intensity was measured using Image J
software (NIH, USA) (Data are not shown)
3. Results
3.1.1. Inheritance of mitochondria
The inheritance of mitochondria was tested in ADHD samples
employing long-template PCR method. The primer sets were designed
for PCR so that the internal primers ampliﬁed a 5.8 kb sequence present
in both thenuclear (chromosome1) andmitochondrial genomes and its
amplicon was nested in that of the external primers, which ampliﬁed a
5.9 kb mtDNA-speciﬁc sequence (Fig. 1A). In case of SH-SY5Y, control
and ADHD cybrids PCR product of external and internal primers isFig. 1. Long-template PCR analysis and PicoGreen® staining of cybrids, ρ0-cells and SH-SY5Y
using both internal and external primers and subjected to electrophoresis on 0.6% agarose gel. A
and nuclei are ﬂuorescent in SH-SY5Y cells, control and ADHD cybrids, whereas in ρ0 cells onl
control cybrids, ADHD1, 5 and 6 are cybrids prepared using platelets of ADHD probands. Scaleobtained, while in ρ0 cells lackingmitochondria, only nuclear sequence
ampliﬁed by internal primers was observed. PicoGreen dye binds to
minor groove of double stranded DNA and gives green ﬂuorescence,
so we can see the punctate mitochondria in the cytoplasm of SH-SY5Y
cells. The punctate ﬂuorescence is absent in ρ0 cells, but show only nu-
clear ﬂuorescence because they do not contain mtDNA (Fig. 1B). The
punctates observed in control, ADHD cybrids conﬁrm their
inheritance of mitochondria from platelets of healthy individuals
and patients.
3.1.2. ADHD cybrids show reduced mitochondrial mass and membrane
potential
Mitotracker Green enters mitochondrial matrix where it covalently
reacts with free thiol groups of cysteine residues of mitochondrial
proteins and produce green ﬂuorescence which allows visualization of
the mitochondria. SH-SY5Y cells are showing elongated mitochondria
and ρ0 cells have fragmented mitochondria (Fig. 2A). Bar diagrams
represents the ﬂuorescence intensity in the control and ADHD cybrids
measured using Image J software which shows signiﬁcant reduction in
ADHD cybrids compared to controls (Fig. 2B). Mitochondrialmembrane
potential was examined in cybrid neurons with TMRM staining
followed by spectroﬂuorimetric (Fig. 2C) quantiﬁcation as well as ﬂow
cytometric (Fig. 2E and F) procedure. Signiﬁcantly low TMRM ﬂuores-
cence observed in ADHD cybrid-neurons implied higher mitochondrial
depolarisation in these cells. Mitochondrial membrane potential was
also analysed in differentiated cybrid neurons [20] by ﬂuorimetric and
FACS analysis and we observed similar results (data are not shown) as
in undifferentiated neurons.
3.1.3. Higher mitochondrial oxidative stress in ADHD cybrids
Likewise MitoSOX™ staining was carried out to test the mito-
chondrial oxidative stress generated in these cybrids neurons
employing spectroﬂuorimetric (Fig. 2D) and ﬂow cytometric (Fig. 2Gcells: (A)Genomic DNA from SH-SY5Y, ρ0-cells, control and ADHD cybrids were ampliﬁed
mplicons are absent in the PCR using external primers for ρ0 cells. (B) Punctated cytoplasm
y the nuclei exhibited green ﬂuorescence by Pico-green staining. C6, C9, C10 and C11 are
bar represents 10 μm.
Fig. 2. Mitotracker Green®, TMRM and MitoSOX™ staining of control and ADHD cybrids: (A) Confocal images of Mitotracker Green® staining of the cybrids. (B) The intensity
of Mitotracker Green® ﬂuorescence quantiﬁed by Image J software. (C & D) The graphs showing the percent change of TMRM and MitoSOX™ ﬂuorescence staining measured
by ﬂuorimetry and (E & G) FACS analysis, in ADHD as compared to the control cybrids. (F & H) are the representative scan of cybrids. Data are presented as Mean ± SEM. Values of
p* ≤ 0.05 are considered signiﬁcant. C6 and C9 are control cybrids, ADHD1, 5 and 6 are cybrids prepared using platelets of ADHD probands. Scale bar represents 10 μm.
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superoxide radicals, as evidenced from the signiﬁcantly increased
MitoSOX™ ﬂuorescence in the cells.
3.1.4. Reduced oxygen consumption due to complex V deﬁciency in diseased
cybrids
Oxygen consumption was monitored in controls and ADHD non-
permeabilized (Fig. 3A and B) and permeabilized cells (Fig. 3C and
D) employing a sensitive Oxygraph in order to understand the respira-
tory capability of the cybrids. Signiﬁcantly reduced rate of respiration
found in ADHD cybrids, as well as in the mitochondria of these
disease-cybrids, pointed to a signiﬁcant loss of mitochondrial functions
in both these diseases. Lower respiration rate could be resulting from
the considerable loss in theATPase 6/8 transcript levels in ADHD cybrids
revealed in quantitative PCR analysis as seen in the present study
(Fig. 3E and F).
3.1.5. Higher level of 5HT in ADHD cybrid neurons and reduced activity of
complex V
Serotonin level, measured by HPLC-ECD in differentiated neurons,
was found to be higher in ADHD cybrids as compared to controls
(Fig. 3G). BN-PAGE in-gel activity studies demonstrated a signiﬁcant
deﬁciency in mitochondrial complex V activity in ADHD cybrids, when
compared to the control cybrids (Fig. 3H to J).
4. Discussion
Most important feature of the present study is the successful
creation of control and ADHD cybrids from an east-Indian population.This is conﬁrmed by successful incorporation of mtDNA into ρ0-cells,
which did not have mtDNA before fusion with the patient or control
platelets. This is the ﬁrst ever report on production of mitochondrial
cell-hybrids (cybrids) for the neurodevelopmental disorder, ADHD. An-
other important attribute of this study is the ﬁnding of signiﬁcantmito-
chondrial aberrations and dysfunctions, as evidenced by reduced
staining intensity of Mitotracker Green®, TMRM and increase in
MitoSOX ﬂuorescence, and signiﬁcant reduction in oxygen consump-
tion concurrent with low levels of ATPase 6/8 transcripts in ADHD
cybrids in comparison to control cybrid-neurons. These observations
support a signiﬁcant bioenergetic crisis in ADHD, which was proposed
[9], but never demonstrated. The third important observation made in
the present study is the signiﬁcant increase in the levels of serotonin
in the differentiated ADHD cybrid-neurons as compared to control
cybrid-neurons, which is a topic of interest and intense debate.
Mitotracker green dye accumulates in the mitochondrial matrix
where it covalently reacts with free thiol groups of cysteine residues
and produce green ﬂuorescence and allows to visualize the mostly
inter-netted, tubular ﬂuorescing mitochondria in the cytoplasm of
control cybrids, but punctate (due to fragmented mitochondria)
ﬂuorescence in diseased cybrids. Quantiﬁcation of mitotracker green
staining by ImageJ software gives the total mass of the mitochondria
present in the cytosol [23] which was found less in ADHD cybrids as
compared to the control cybrids. This data speculates that due to frag-
mentation of mitochondria the total mass in the cytoplasm decreases.
Signiﬁcantly low TMRM ﬂuorescence observed in ADHD cybrid-
neurons implied higher mitochondrial depolarisation in these cells.
No report is available in literature which deals with mitochondrial
membrane potential and ADHD, and therefore the present report is
Fig. 3.Whole cell andmitochondrial state3 respiration, APTase6/8 subunits expression, complexV activity and serotonin levels in control andADHD cybrids:Whole cell respiration
(A), cellular rate of oxygen consumption per 3×106 cells (B), mitochondrial State3 respiration (C), and mitochondrial oxygen consumption rate per 3×106 cells in ADHD and control
cybrids (D). The cDNA prepared from total RNA of ADHD and control cybrids were subjected to qRT-PCR analysis using speciﬁc primers to accurately measure the transcript level of
ATPase6/8 (E, F). Levels of serotonin in differentiated control and ADHD cybrid-neurons (G). Complex V activity using BN-PAGE, Activity gel (H), Coomassie staining gel (I). Bar
diagram shows the difference in complex V activity analysed by Image software (J). (Control samples- 1 to 4 lanes and ADHD samples- 5 to 7 lanes in both the gels, M lane is marker).
Data are presented as Mean ± SEM. Values of p* ≤ 0.05 is considered signiﬁcant.
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ide radicals, as evidenced from the signiﬁcantly increased MitoSOX™
ﬂuorescence in the cells. These amply provide proof that in ADHD
there exist a serious oxidative stress condition, and that could be detri-
mental to the health of the neurons. In one study (48 children and ado-
lescents (34 male, 14 female) with ADHD who had no neurological,
systemic, or comorbid psychiatric disorders, and 24 sex- and age-
matched healthy controls (17 male and seven female), it was observed
that ADHD patients have oxidative imbalance [24]. In one another study
one group investigated total antioxidative status and total oxidative
status of plasma and antioxidant enzyme. Oxidative stress index values
and the plasma TOS levels of the patients with ADHD were statistically
higher than those of the control group [25]. Sezen et al. [26] also inves-
tigated and found that oxidative stresswas higher in the ADHD patients
than the control group. Bioenergetic dysregulation playing key roles in
many neuropsychiatric disorders is recently reviewed [27]. This may
result from defective mitochondrial ETC complex function, which is
validated by a signiﬁcant decrease in state3 respiration in ADHDcybrids.
Considerable decrease in the ETC complex V ATPase 6/8 subunits in
ADHD cybrids further provides positive evidences in this direction.
ATPase 6/8 mutations are associated with many neurodevelopmental
disorders including autism [28,29], with which ADHD shows overlap-
ping syndromes [30]. The decreased transcript level of ATP6 and ATP8
subunits may lead to the lower activity of complex V in ADHD cybrids
as our BN-PAGE data shows.These evidences ﬁrmly suggest that
mitochondrial dysfunction exists in ADHD.
The status of mitochondrial energetics in ADHD subjects is not avail-
able. However, indirect evidences from pharmacological studies using
methylphenidate, which is a drug commonly used to treat ADHD haveshown that the drug affects the activity of mitochondrial ETC enzymes
and results in increase of the extracellular levels of the catecholamines
that stimulate glycolysis and release of lactate from the astrocytes,
thereby correcting the energy deﬁciency, and restoring appropriate ﬁr-
ing rates [10]. This has led to the hypothesis that impairment of
mitochondrial bioenergetic machinery may play a role in autism and
ADHD pathogenesis [9,31].
Serotoninergic system, known to modulate impulse control and
aggression, is challenged in ADHD patients [32]. At a time when
mitochondrially-located MAO-A or MAO-B were unaffected in ADHD
cybrids, the differentiated cybrid-neurons from ADHD probands
exhibited 2-fold increase in serotonin indicating probably an active
role of this biogenic amine in the phenotypes of the disease. If this is
proved to be true, these cybrid-neurons can be used as a cellular
model for ADHD to investigate neuromolecularmechanisms underlying
ADHD pathology.
At a time when no direct evidence of mitochondrial dysfunctions
in ADHD is available, we created and used ADHD cybrids to assess
mitochondrial functions in this neurodevelopmental disorder. Cybrids
created by fusion of ρ0-cells and Parkinson’s disease (PD) patient
platelets are shown to replicate mitochondrial pathology seen in post-
mortem PD brains [11], and differentiation of these cells into neurons
are demonstrated to retain the mitochondrial defects [22]. Therefore,
ADHD cybrids and the cybrid-neurons created in the present report
could be reliable tools to study the mitochondrial dynamics and
bioenergetics, and to understand themolecularmechanismsunderlying
the pathophysiology of ADHD.
In short, this is the ﬁrst report that identiﬁes mitochondrial dysfunc-
tion as an inherent factor of ADHD pathology, and for probable direct
158 P. Verma et al. / BBA Clinical 6 (2016) 153–158role of serotoninergic system in the disease syndromes. Increased
serotonin content in the differentiated cybrid-neurons suggests that
the mitochondrial defect in these cells can signiﬁcantly alter the
serotonergic neurotransmitter function, which could be a pathological
hallmark of ADHD. This study identiﬁes mitochondrial pathology as
one of the risk factors for ADHD, and the cybrid model provides a
novel, reliable and valid tool to study the molecular basis of ADHD at
cellular level.
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